These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 25200689

  • 21. Up-regulation of soluble vascular endothelial growth factor receptor-1 prevents angiogenesis in hypertrophied myocardium.
    Kaza E, Ablasser K, Poutias D, Griffiths ER, Saad FA, Hofstaetter JG, del Nido PJ, Friehs I.
    Cardiovasc Res; 2011 Feb 01; 89(2):410-8. PubMed ID: 20935166
    [Abstract] [Full Text] [Related]

  • 22. Assessment of angiogenesis modulators in pregnant women with pre-eclampsia: a case-control study.
    Mundim GJ, Paschoini MC, Araujo Júnior E, Da Silva Costa F, Rodrigues Júnior V.
    Arch Gynecol Obstet; 2016 Feb 01; 293(2):369-75. PubMed ID: 26205065
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus.
    Robak E, Sysa-Jedrzejewska A, Robak T.
    Mediators Inflamm; 2003 Oct 01; 12(5):293-8. PubMed ID: 14760936
    [Abstract] [Full Text] [Related]

  • 26. Increased serum level of soluble vascular endothelial growth factor receptor-1 is associated with poor coronary collateralization in patients with stable coronary artery disease.
    Sun Z, Shen Y, Lu L, Zhang RY, Pu LJ, Zhang Q, Yang ZK, Hu J, Chen QJ, Shen WF.
    Circ J; 2014 Oct 01; 78(5):1191-6. PubMed ID: 24583918
    [Abstract] [Full Text] [Related]

  • 27. The relationship of serum VEGF and sVEGFR-1 levels with vascular involvement in patients with Behçet's disease.
    Sertoglu E, Omma A, Yucel C, Colak S, Sandıkcı SC, Ozgurtas T.
    Scand J Clin Lab Invest; 2018 Oct 01; 78(6):443-449. PubMed ID: 30015524
    [Abstract] [Full Text] [Related]

  • 28. Clinical usefulness of assessing VEGF and soluble receptors sVEGFR-1 and sVEGFR-2 in women with breast cancer.
    Thielemann A, Baszczuk A, Kopczyński Z, Kopczyński P, Grodecka-Gazdecka S.
    Ann Agric Environ Med; 2013 Oct 01; 20(2):293-7. PubMed ID: 23772579
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
    Bdolah Y, Lam C, Rajakumar A, Shivalingappa V, Mutter W, Sachs BP, Lim KH, Bdolah-Abram T, Epstein FH, Karumanchi SA.
    Am J Obstet Gynecol; 2008 Apr 01; 198(4):428.e1-6. PubMed ID: 18191808
    [Abstract] [Full Text] [Related]

  • 32. Soluble and membranous vascular endothelial growth factor receptor-1 in pregnancies complicated by pre-eclampsia.
    Tripathi R, Rath G, Jain A, Salhan S.
    Ann Anat; 2008 Nov 20; 190(5):477-89. PubMed ID: 18992679
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction.
    Kodama Y, Kitta Y, Nakamura T, Takano H, Umetani K, Fujioka D, Saito Y, Kawabata K, Obata JE, Mende A, Kobayashi T, Kugiyama K.
    J Am Coll Cardiol; 2006 Jul 04; 48(1):43-50. PubMed ID: 16814647
    [Abstract] [Full Text] [Related]

  • 35. Determination of serum vascular endothelial growth factor (VEGF) and VEGF receptor levels with VEGF gene polymorphisms in patients with Behçet's uveitis.
    Sertoglu E, Yücel Ç, Omma A, Hayran Y, Colak S, Sandıkçı SC, Durukan AH, Ozgurtas T.
    Adv Clin Exp Med; 2022 Mar 04; 31(3):231-240. PubMed ID: 34918882
    [Abstract] [Full Text] [Related]

  • 36. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
    Aggarwal PK, Chandel N, Jain V, Jha V.
    J Hum Hypertens; 2012 Apr 04; 26(4):236-41. PubMed ID: 21451568
    [Abstract] [Full Text] [Related]

  • 37. The effects of neoadjuvant anastrozole and tamoxifen on circulating vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in breast cancer.
    Banerjee S, Pancholi S, A'hern R, Ghazoui Z, Smith IE, Dowsett M, Martin LA.
    Clin Cancer Res; 2008 May 01; 14(9):2656-63. PubMed ID: 18451229
    [Abstract] [Full Text] [Related]

  • 38. Reduced serum vascular endothelial growth factor receptor-2 (sVEGFR-2) and sVEGFR-1 levels in gastric cancer patients.
    Kikuchi S, Obata Y, Yagyu K, Lin Y, Nakajima T, Kobayashi O, Kikuichi M, Ushijima R, Kurosawa M, Ueda J.
    Cancer Sci; 2011 Apr 01; 102(4):866-9. PubMed ID: 21219538
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.